Open Day 1 of ESOC 2025 in Helsinki: OPTIMIST Trial Highlights
European Stroke Organisation (ESO) has shared an insightful post on X:
”Missed it live? Revisit Day 1 PI insights from ESOC 2025 in Helsinki. Investigators, moderated by Jelle De Meester and Teresa Ullberg, discuss the OPTIMIST main trial – nearly 5,000 patients, 114 hospitals, 8 countries.”
Watch the footage here.
Day 1 of ESOC 2025 in Helsinki featured key insights from the highly anticipated OPTIMIST main trial.
The trial was presented by principal investigators and moderated by Jelle De Meester and Teresa Ullberg.
The large-scale trial enrolled nearly 5,000 patients across 114 hospitals in 8 countries, offering robust data on stroke care optimization.
For those who missed the live session, the discussion provided critical updates on trial methodology, patient outcomes, and future directions in acute stroke management.
A must-watch for clinicians and researchers shaping the next generation of stroke care!
Hemostasis Today, your daily source of latest news on stroke management.
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together